Exiting the EU: our work to ensure the best deal for cancer research and patients

Brexit & the EU

Following the British public’s decision to leave the European Union, we’ll be working hard to help inform negotiations, ensuring cancer patients in the UK and across the EU are prioritised in Brexit talks. 

Health and science are global. And collaboration between the UK and countries in Europe and beyond enables the discoveries that benefit patients everywhere. So we’ll be following progress on the UK’s new relationship with the EU closely and seeking to input our expertise on the issues we care most about.

As the largest independent funder of research in Europe we remain committed to collaborating across borders within Europe, and globally, to beat cancer sooner. 

Read more:

 

Contact us

To request a meeting or further information about our work please contact the Public Affairs team.

Email us

Science Blog: Brexit, cancer research & patients

We’re keen to ensure that cancer patients in the UK and beyond are prominent on the Brexit agenda as the discussions unfold.

Share this page